Biovirtus   Report issue

For profit Phase 1 Phase 3
Founded: Warsaw Poland (2012)

Organization Overview

First Clinical Trial
2014
NCT02040597
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Research Site Ltd